Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-19-007350
Filing Date
2019-02-12
Accepted
2019-02-12 09:04:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a19-3280_2sc13ga.htm SC 13G/A 79350
2 EX-99.1 a19-3280_2ex99d1.htm EX-99.1 7886
  Complete submission text file 0001104659-19-007350.txt   89067
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51477 | Film No.: 19587847
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 617 772-8500
Tekla Capital Management LLC (Filed by) CIK: 0001300336 (see all company filings)

EIN.: 010628853 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A